IGF-1 DES vs Somatropin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
IGF-1 DES (des(1-3)IGF-1) is a naturally occurring truncated form of IGF-1, produced endogenously in the brain and other tissues, that lacks the first three N-terminal amino acids (Gly-Pro-Glu) of full-length IGF-1. This truncation eliminates its binding to IGF-binding proteins (...
Calculate IGF-1 DES dose →Somatropin is recombinant human growth hormone (rhGH) - a 191 amino acid protein identical to endogenous pituitary GH, produced via recombinant DNA technology. It is FDA-approved for multiple indications including pediatric and adult growth hormone deficiency, Turner syndrome, HI...
Calculate Somatropin dose →| Parameter | IGF-1 DES | Somatropin |
|---|---|---|
| Category | Growth Hormone & IGF | Growth Hormone & IGF |
| Research | Research Use | FDA Approved |
| Half-Life | 20–30 minutes (shorter than IGF-1 LR3) | ~3–4 hours (SubQ); ~20 min (IV) |
| Typical Dose | 50–100 µg | 0.1–0.3 mg/day (GHD); up to 2 mg/day (clinical indications) |
| Frequency | 1–2x daily (peri-workout) | Daily or 6 days/week |
| Route | Subcutaneous / Intramuscular (local) | Subcutaneous / Intramuscular |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.